Results 41 to 50 of about 53,413 (292)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Identification of pneumonia and influenza deaths using the death certificate pipeline
BMC Medical Informatics and Decision Making, 2012 Background Death records are a rich source of data, which can be used to assist with public surveillance and/or decision support. However, to use this type of data for such purposes it has to be transformed into a coded format to make it computable ...
Davis Kailah +4 more
doaj +1 more source
Automatic Identification of Individual Drugs in Death Certificates. [PDF]
Stud Health Technol Inform, 2019 Background: Establishing trends of drug overdoses requires the identification of individual drugs in death certificates, not supported by coding with the International Classification of Diseases.
Kho SJ, Sheth A, Bodenreider O.
europepmc +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To assess the association and discriminative performance of serum biomarkers with clinical disease progression and survival in patients with amyotrophic lateral sclerosis (ALS). Methods This retrospective study, conducted at Houston Methodist Hospital, Houston, TX, used longitudinal serum samples collected between January 2018 and ...
David R. Beers +7 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak +4 more
wiley +1 more source
Evaluation of Errors on Death Certificates
Journal of Nepal Health Research CouncilBackground: Death certificates provide vital data for disease surveillance and health policy. However, errors are common globally, undermining data reliability.
Alok Atreya +4 more
doaj +1 more source
Reforming death certification [PDF]
BMJ, 2006 EDITOR—The government has cited cost and bureaucracy as reasons for not reforming death certification, as recommended by the Luce report and by Dame Janet Smith's report into the Shipman affair. …
openaire +2 more sources
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Inadequacies of death certification in Beirut: who is responsible?
Bulletin of the World Health OrganizationOBJECTIVE: To assess the completeness of data on death certificates over the past 25 years in Beirut, Lebanon, and to examine factors associated with the absence of certifiers' signatures and the non-reporting of the underlying cause of death. METHODS: A
Abla M. Sibai +3 more
doaj +1 more source